Veronica Galvan
3Patents
1h-index
7Co-inventors
37Inventor score
Filing activity: Apr 23, 2004 → Aug 27, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11110067B2 | Inhibition of mammalian target of rapamycin | Human Necessities | 6 | Active |
| US7544855B2 | Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664 | Physics | 0 | Expired |
| US8329653B2 | Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.